BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26468534)

  • 1. Kaposi's Sarcoma-Associated Herpesvirus Reduces Cellular Myeloid Differentiation Primary-Response Gene 88 (MyD88) Expression via Modulation of Its RNA.
    Lingel A; Ehlers E; Wang Q; Cao M; Wood C; Lin R; Zhang L
    J Virol; 2016 Jan; 90(1):180-8. PubMed ID: 26468534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaposi's sarcoma-associated herpesvirus-encoded replication and transcription activator impairs innate immunity via ubiquitin-mediated degradation of myeloid differentiation factor 88.
    Zhao Q; Liang D; Sun R; Jia B; Xia T; Xiao H; Lan K
    J Virol; 2015 Jan; 89(1):415-27. PubMed ID: 25320320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi sarcoma-associated herpesvirus degrades cellular Toll-interleukin-1 receptor domain-containing adaptor-inducing beta-interferon (TRIF).
    Ahmad H; Gubbels R; Ehlers E; Meyer F; Waterbury T; Lin R; Zhang L
    J Biol Chem; 2011 Mar; 286(10):7865-7872. PubMed ID: 21212282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanylate-Binding Protein 1 Inhibits Nuclear Delivery of Kaposi's Sarcoma-Associated Herpesvirus Virions by Disrupting Formation of Actin Filament.
    Zou Z; Meng Z; Ma C; Liang D; Sun R; Lan K
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28592529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major Histocompatibility Complex Class II HLA-DRα Is Downregulated by Kaposi's Sarcoma-Associated Herpesvirus-Encoded Lytic Transactivator RTA and MARCH8.
    Sun Z; Jha HC; Pei YG; Robertson ES
    J Virol; 2016 Sep; 90(18):8047-58. PubMed ID: 27356905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR-TRIF pathway enhances the expression of KSHV replication and transcription activator.
    Meyer F; Ehlers E; Steadman A; Waterbury T; Cao M; Zhang L
    J Biol Chem; 2013 Jul; 288(28):20435-42. PubMed ID: 23723066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 modulate the Toll-like receptor-induced proinflammatory cytokine response.
    Bussey KA; Reimer E; Todt H; Denker B; Gallo A; Konrad A; Ottinger M; Adler H; Stürzl M; Brune W; Brinkmann MM
    J Virol; 2014 Aug; 88(16):9245-59. PubMed ID: 24899179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus-Like Vesicles of Kaposi's Sarcoma-Associated Herpesvirus Activate Lytic Replication by Triggering Differentiation Signaling.
    Gong D; Dai X; Xiao Y; Du Y; Chapa TJ; Johnson JR; Li X; Krogan NJ; Deng H; Wu TT; Sun R
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28515293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.
    Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C
    J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
    Lan K; Kuppers DA; Verma SC; Robertson ES
    J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB serves as a cellular sensor of Kaposi's sarcoma-associated herpesvirus latency and negatively regulates K-Rta by antagonizing the RBP-Jkappa coactivator.
    Izumiya Y; Izumiya C; Hsia D; Ellison TJ; Luciw PA; Kung HJ
    J Virol; 2009 May; 83(9):4435-46. PubMed ID: 19244329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KSHV RTA Induces Degradation of the Host Transcription Repressor ID2 To Promote the Viral Lytic Cycle.
    Combs LR; Spires LM; Alonso JD; Papp B; Toth Z
    J Virol; 2022 Jun; 96(12):e0010122. PubMed ID: 35604218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcriptional repressor K-RBP modulates RTA-mediated transactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus.
    Yang Z; Wood C
    J Virol; 2007 Jun; 81(12):6294-306. PubMed ID: 17409159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication Interferes with mTORC1 Regulation of Autophagy and Viral Protein Synthesis.
    Pringle ES; Robinson CA; McCormick C
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31375594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-Adrenoreceptors reactivate Kaposi's sarcoma-associated herpesvirus lytic replication via PKA-dependent control of viral RTA.
    Chang M; Brown HJ; Collado-Hidalgo A; Arevalo JM; Galic Z; Symensma TL; Tanaka L; Deng H; Zack JA; Sun R; Cole SW
    J Virol; 2005 Nov; 79(21):13538-47. PubMed ID: 16227274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular corepressor TLE2 inhibits replication-and-transcription- activator-mediated transactivation and lytic reactivation of Kaposi's sarcoma-associated herpesvirus.
    He Z; Liu Y; Liang D; Wang Z; Robertson ES; Lan K
    J Virol; 2010 Feb; 84(4):2047-62. PubMed ID: 19939918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.
    Lan K; Kuppers DA; Verma SC; Sharma N; Murakami M; Robertson ES
    J Virol; 2005 Jun; 79(12):7453-65. PubMed ID: 15919901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine-Tuning of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle in Neighboring Cells through the RTA-JAG1-Notch Pathway.
    Li S; Hu H; He Z; Liang D; Sun R; Lan K
    PLoS Pathog; 2016 Oct; 12(10):e1005900. PubMed ID: 27760204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression.
    Abend JR; Ramalingam D; Kieffer-Kwon P; Uldrick TS; Yarchoan R; Ziegelbauer JM
    J Virol; 2012 Nov; 86(21):11663-74. PubMed ID: 22896623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.